08622 HUAKANG BIOMED
Trading Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 4.90X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | N/A | Net Margin | N/A |
Total Debt/Equity | 2.2% | Return on Equity | N/A |
Price/Book | 3.09X | Return on Assets | N/A |
(HKD 0.355) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -4.42 | -6.37 | -3.45 | -5.16 | -13.80 |
---|---|---|---|---|---|
Net Profit Growth (%) | +30.6 | -84.9 | +33.2 | +62.6 | -4,246.3 |
Earnings Per Share (HKD) | -0.009 | -0.015 | -0.009 | -0.013 | -0.035 |
Earnings Per Share Growth (%) | +39.9 | -80.0 | +34.1 | +62.6 | -4,212.5 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 0.115 | 0.134 | 0.153 | 0.176 | 0.184 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 25.359 | 24.629 | +3.0 | 25.33 |
Operating Result | -4.158 | -5.782 | -28.1 | -3.007 |
Associates | 0 | 0 | N/A | 0 |
Profit Before Taxation | -4.158 | -5.782 | -28.1 | -3.007 |
Taxation | 0 | 0 | N/A | 0.068 |
Profit /( Loss) After Taxation | -4.158 | -5.782 | -28.1 | -3.075 |
Net Profit | -4.158 | -5.782 | -28.1 | -3.075 |
Earnings Per Share () | -0.0092 | -0.0153 | -39.9 | -0.0085 |
Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-03-24 |
* Annualised
Last Update Time: 2025-07-22 21:40:25